Published Date: 22 Apr 2023
The US News and World Report rankings, once the benchmark by which students evaluated medical schools, have recently begun to lose some of their sway. The value of a school can be evaluated in various ways, according to medical students.
Read Full NewsAs part of NeurologyLive®'s Year in Review 2025, we've compiled some of the top trending migraine trials.
At ECTRIMS 2025, the William S. and Lois Stiles Edgerly Professor of Neurology at Yale School of Medicine discussed evolving insights into the disease pathogenesis of multiple sclerosis.
As part of NeurologyLive®'s Year in Review, take a look at our top expert interviews on the latest advances and use of artificial intelligence in neurology care.
Fibromyalgia in 2025: Year in Review
Rheumatoid Arthritis in 2025: Year in Review
Asthma in 2025: Year in Review
C3 Glomerulopathy in 2025: Year in Review
1.
Losing a reward can affect your motivation and performance.
2.
Prostate cancer Q&A: Improving detection and reducing overtreatment
3.
Taking Charge of Your Cancer Journey.
4.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
5.
Outcomes in Resected Melanoma Influenced by Timing of Recurrence
1.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
2.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
3.
An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025
4.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
5.
The Cutting-Edge of Phlebectomy: Redefining Vein Care
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation